FeesSafety
Pluang+

MiniMed Group shifts from share donor to taker amid 15.8% Q1 growth and new product launches

Market News
18 Nov 2026, 12:02 WIB
Seeking Alpha
View Source
Bullish
MiniMed Group shifts from share donor to taker amid 15.8% Q1 growth and new product launches

MiniMed Group's Q1 organic growth accelerated to 15.8%, driven by over 20% rise in new U.S. pump volumes, supporting a business with about 80% recurring revenue. The company is transitioning from being a share donor to a share taker as it navigates its split-off process, which currently obscures its product-cycle progress. Upcoming products like Flex, the Fit patch pump, and Vivera could complete its portfolio by late 2027, though regulatory, competitive, and separation risks remain. Despite current pricing reflecting separation concerns rather than business performance, easing split-off supply and improved cash conversion could support a recovery in valuation.

MiniMed Group's stock trades at USD 17.74 on Pluang as of Nov 18, 2026 17:21 WIB, down slightly by 0.22% for the day. This price sits closer to its 52-week low of USD 10.80 than its high of USD 23.84, reflecting ongoing market caution possibly linked to the split-off process mentioned in the news. Despite this, all current Pluang orders are buys, indicating investor interest amid the company's evolving product cycle and growth prospects.

More News (MMED)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App